The Food Production Environment and the Development of Antimicrobial Resistance in Human Pathogens of Animal Origin
Open accessThe DOI matches its Crossref record; 121 of the 122 references it cites were found in a registry or an index; none of the 37 sources its claims cite is checked for support yet.
Abstract
Food-borne pathogens are a serious human health concern worldwide, and the emergence of antibiotic-resistant food pathogens has further confounded this problem. Once-highly-efficacious antibiotics are gradually becoming ineffective against many important pathogens, resulting in severe treatment crises. Among several reasons for the development and spread of antimicrobial resistance, their overuse in animal food production systems for purposes other than treatment of infections is prominent. Many pathogens of animals are zoonotic, and therefore any development of resistance in pathogens associated with food animals can spread to humans through the food chain. Human infections by antibiotic-resistant pathogens such as Campylobacter spp., Salmonella spp., Escherichia coli and Staphylococcus aureus are increasing. Considering the human health risk due to emerging antibiotic resistance in food animal–associated bacteria, many countries have banned the use of antibiotic growth promoters and the application in animals of antibiotics critically important in human medicine. Concerted global efforts are necessary to minimize the use of antimicrobials in food animals in order to control the development of antibiotic resistance in these systems and their spread to humans via food and water.
Overview
CoChat Summary
## TL;DR
This paper argues that antimicrobial use in food animals, especially non-therapeutic uses such as growth promotion and prophylaxis, is a major driver of antimicrobial resistance that can spread to humans through the food chain, environment, and farm contact. It supports this with examples and surveillance data showing resistance increases after use of specific drugs and decreases after bans or restrictions.
## Key findings
- The paper states that, globally, 63,200 tons of antibiotics were used in livestock in 2010, and this is estimated to rise by 67% to 105,600 tons by 2030.
- In the United States, an estimate from 2012 found that 72.5% of 12,272 tons of medically important antibiotics were used in animals and 27.5% in humans; it also says nearly 80% of antibiotics produced in the U.S. are used in animal husbandry.
- It reports that food animals and workers on farms using AGPs harbor more antibiotic-resistant bacteria than those from farms not using AGPs, and a U.S. study found poultry workers had a 32-times-higher risk of carrying gentamicin-resistant E. coli than community referents.
- Specific examples link use and resistance: avoparcin in chicks led to vancomycin-resistant Enterococcus faecium (VRE), and banning avoparcin in the European Union in 1997 decreased VRE in poultry and the community; reduced tylosin use in 1998–1999 was followed by decreased erythromycin resistance in E. faecium and E. faecalis from pigs.
## Methods
- Not stated in the paper.
- The article is a narrative review that synthesizes prior studies, surveillance reports, and policy examples on antimicrobial use in food production and resistance development.
- Its main analysis is qualitative: it links mechanisms of resistance with historical and current evidence from livestock, poultry, aquaculture, farm workers, and human infections.
## Limitations
- The paper states that “the actual impact of the effect of antimicrobial use and the resultant resistance development by human pathogenic bacteria is a topic of intense debate.”
- It also notes that “a multiplicity of factors contribute to AMR development,” suggesting antimicrobial use is not the only driver.
- Evident from the text: the paper is a broad review rather than an original empirical study, so its conclusions depend on previously published studies and examples rather than a single unified dataset.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
0 Valid · 2 Not valid · 28 Not checked · 8 Own results and interpretations
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“However, there is no evidence to directly link human infections of LA-MRSA to their livestock origin.”
§ The Food Production Environment and the Development of Antimicrobial Resistance in Human Pathogens of Animal Origin > 4. Antimicrobial Use and the Development of Resistance in Food Production Environments The use of antimicrobials in animal husbandry and the resultant development of antibiotic resistance in bacteria is recognized as a potential human health concern for various reasons, such as: (i) the antibiotic-resistant bacteria associated with animals may be pathogenic to humans; (ii) antibiotic-resistant bacteria can be easily transmitted to humans via food from farm animals; (iii) these antibiotic-resistant bacteria can spread to the environment through animal waste leading to wider dissemination; (iv) bacteria can transmit their resistance genotypes to human pathogens not associated with the animals via genetic element transfer mechanisms [79]. Several studies have shown that the regular use of antimicrobials in food animals and birds results in the development of antimicrobial resistance among commensal bacteria. A recent study involving seven European countries found a strong correlation between the levels of antimicrobials used and the resistances of commensal E. coli isolates towards those antibiotics in pigs, poultry and cattle [80]. The use of low-dose, sub-therapeutic concentrations in animal systems results in the selection of a resistant population of bacteria which colonize the animal surface, the gut and the rearing environment [81,82]. The effect of antimicrobial use is not restricted to the farm environment. Since a substantial quantity of antimicrobials is excreted by the animals via feces, environmental contamination with sub-lethal concentrations of antimicrobials occurs [83]. Environmental bacteria exposed to sub-lethal concentrations of antimicrobials can develop resistance, and through genetic exchange mechanisms, the resistance phenotype gets gradually disseminated among pathogenic and non-pathogenic bacteria. An environmental resistome builds up which can lead to wider dissemination of resistant bacteria [84]. The presence of antibiotics in foods consumed by humans has its own implications on antibiotic resistance development by the human gut microbiome [85]. The connection between antibiotic use and resistance development was first observed in E. coli isolated from the gut of chickens fed with streptomycin [86]. Some of the important pathogens of particular consideration with respect to their development of resistance to the above three classes of drugs include Clostridium difficile, Campylobacter, Salmonella, Shigella, and S. aureus. Currently, several antimicrobials of human medical use are being used in livestock, poultry, and aquaculture (Table 2). Some of these such as the fluoroquinolones are critical for the treatment of Gram-negative infections in humans, and their use in food animals may jeopardize the efficacy of these antibiotics due to the development of resistance in pathogens of zoonotic potential [87]. Scientifically based investigations suggest a strong relationship between antibiotic use in food animals and the development of antibiotic resistance by bacteria associated with farm animals [88,89,90]. There are numerous documented instances in which the introduction of an antibiotic as an AGP or for the treatment of specific infections resulted in the emergence of antibiotic-resistant bacterial variants [91]. Food animals and workers on farms using AGPs harbor more antibiotic-resistant bacteria compared to those from farms not using AGPs [92]. Antibiotic-resistant bacteria associated with food animals has resulted in their dissemination via the food chain and into the environment, and in farm workers being the carriers of such bacteria [81,93]. A study in the USA revealed that poultry workers had a 32-times-higher risk of carrying gentamicin-resistant E. coli compared with community referents [94]. It has been experimentally shown that the use of avoparcin in chicks resulted in the development of vancomycin resistance by Enterococcus faecium (VRE), and such bacteria could be transmitted to humans via their consumption of meat contaminated with VRE [74]. Prohibition of avoparcin in European Union countries in 1997 resulted in a decrease of VRE in poultry and in the community [95]. The decrease in the use of tylosin during 1998 and 1999 was followed by a decrease in erythromycin resistance among E. faecium and E. faecalis isolates from pigs [96]. An increased occurrence of virginiamycin resistance among E. faecium isolates in broilers correlated with the increased use of virginiamycin during 1995 to 1997 in Denmark, and the subsequent ban on the use of virginiamycin in 1998 resulted in a decrease in the resistance [96]. A strong correlation between the use of sub-therapeutic concentrations of tetracycline, alone or in combination with sulfamethazine, and the carriage of resistant strains of Campylobacter species in feedlot cattle has been demonstrated [97]. Quinolonesand third and fourth generation cephalosporins are important in treating salmonellosis in humans, and their widespread use in animal husbandry has selected for resistant strains that can potentially jeopardize their human clinical application [98]. A surveillance study in the USA revealed a strong association between the rise in ciprofloxacin resistance in Campylobacter spp. and the use of fluoroquinolones such as sarafloxacin and enrofloxacin in food-producing animals [99]. A sharp rise in ciprofloxacin resistance in Campylobacter as a result of the use of fluoroquinolones in food-producing animals has been reported from Denmark, Spain and the Netherlands [88,100]. The introduction of fluoroquinolones for the treatment of respiratory diseases led to the emergence of fluoroquinolone-resistant Campylobacter [88,101]. The use of third generation cephalosporins led to an increase in the number of cephalosporin-resistant Salmonella strains [102]. A study by Alexander et al. [103] has shown that sub-therapeutic administration of tetracycline in combination with sulfamethazine increased the prevalence of tetracycline- and AMP-resistant E. coli in cattle. The development of multidrug resistance in E. coli and Salmonella in swine fed with antimicrobial feed has been reported by several investigators [104,105,106,107]. Similarly, it has been reported that macrolides, which are widely used in food animals, result in the selection of macrolide-resistant Campylobacter spp. [98]. Considering the importance of macrolides in the treatment of Campylobacter infections in children, its use in food animals requires critical rethinking. Another serious pathogen associated with livestock and which poses the danger of transmission via food-producing animals is the methicillin-resistant Staphylococcus aureus (MRSA). A particular sequence type, ST398, of livestock-associated MRSA (LA-MRSA) has also been found in farm facilities and in farm workers [108]. However, there is no evidence to directly link human infections of LA-MRSA to their livestock origin. Historically, when antimicrobial agents were first used in agriculture, such as in food production environments, bacterial multidrug-resistant variants of S. enterica and E. coli soon emerged [109,110]. Shortly after the emergence of this multidrug resistance occurred, transfer of the resistance determinants was detected in the form of plasmids, thus facilitating their movement from food animals to humans and the subsequent transmission to the gastrointestinal tract of new human hosts [91,111]. Together, mobile genetic transfer elements (e.g., bacteriophages, plasmids, gene cassettes, integrons, transposons) and various modes of infection transmission (e.g., direct food animal to human and food-borne) have facilitated the spread of newly emerged resistance determinants from food animals and their food products to humans and their communities, as a consequence of exposure to sub-lethal concentrations of antimicrobial agents [112,113]. These sub-inhibitory concentrations of antimicrobial agents used in agriculture exert selective evolutionary pressures upon the populations of bacteria that reside in food production environments, resulting in the emergence and subsequent predominance of multidrug-resistant variants [52,114]. Such multidrug-resistant variants have included Gram-positive and –negative bacteria such as Enterococcus spp. [115], Lactococcus spp. [116], Lactobacillus spp. [117], S. aureus [118], and Gram-negative bacteria such as E. coli [119], Campylobacter spp. [120], Listeria monocytogenes [121] and S. enterica [54,122]. Consequently, it has since been widely documented that antimicrobial use in food animals correlates not only with the emergence of bacterial multidrug resistance but also with the spread of infectious diseases that are recalcitrant to efficacious chemotherapy in humans [92,114,123,124]. Policy practices implemented in Europe in which antimicrobial non-therapeutic uses are completely banned (e.g., avoparcin and virginiamycin) in agriculture settings have resulted in reductions in both the prevalence of multidrug-resistant pathogens and in the minimal inhibitory concentrations (MICs) for clinically relevant antimicrobials, such as vancomycin [92,124]. Despite the extensive amount of work over a span of 50 years definitively demonstrating an association between antimicrobial agents and the incidence and prevalence of multiple drug-resistant microorganisms in food production circles [125], the issue remains surprisingly controversial in agriculture, but apparently not in human healthcare settings. Therefore, with respect to antimicrobial usage in agriculture, more work will be necessary to gain a fuller understanding of the nature and extent of the resistance prevalence problem, the overall efficacy of the antimicrobial bans, and the resulting improvement in human health [92]. A review study by the European Food Safety Authority (EFSA) and the European Medicines Agency (EMA) on the impact of measures taken to reduce the use of antimicrobials in food-producing animals on the occurrence of antimicrobial resistance (AMR) in bacteria from food-producing animals suggested an association between the reduction in antimicrobial use and reduced AMR [126], although a multiplicity of factors contribute to AMR development. An integrated approach involving different stakeholders to reduce the use of antimicrobials in animals has been recommended, which emphasizes better management practices to reduce the risks of disease, searching for alternative strategies such as competitive exclusion of pathogens, immunostimulants, probiotics, and bacteriophages, and avoiding the preventive use of antimicrobials, etc. [126].
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“These sub-inhibitory concentrations of antimicrobial agents used in agriculture exert selective evolutionary pressures upon the populations of bacteria that reside in food production environments, resulting in the emergence and subsequent predominance of multidrug-resistant variants [52,114].”
§ The Food Production Environment and the Development of Antimicrobial Resistance in Human Pathogens of Animal Origin > 4. Antimicrobial Use and the Development of Resistance in Food Production Environments The use of antimicrobials in animal husbandry and the resultant development of antibiotic resistance in bacteria is recognized as a potential human health concern for various reasons, such as: (i) the antibiotic-resistant bacteria associated with animals may be pathogenic to humans; (ii) antibiotic-resistant bacteria can be easily transmitted to humans via food from farm animals; (iii) these antibiotic-resistant bacteria can spread to the environment through animal waste leading to wider dissemination; (iv) bacteria can transmit their resistance genotypes to human pathogens not associated with the animals via genetic element transfer mechanisms [79]. Several studies have shown that the regular use of antimicrobials in food animals and birds results in the development of antimicrobial resistance among commensal bacteria. A recent study involving seven European countries found a strong correlation between the levels of antimicrobials used and the resistances of commensal E. coli isolates towards those antibiotics in pigs, poultry and cattle [80]. The use of low-dose, sub-therapeutic concentrations in animal systems results in the selection of a resistant population of bacteria which colonize the animal surface, the gut and the rearing environment [81,82]. The effect of antimicrobial use is not restricted to the farm environment. Since a substantial quantity of antimicrobials is excreted by the animals via feces, environmental contamination with sub-lethal concentrations of antimicrobials occurs [83]. Environmental bacteria exposed to sub-lethal concentrations of antimicrobials can develop resistance, and through genetic exchange mechanisms, the resistance phenotype gets gradually disseminated among pathogenic and non-pathogenic bacteria. An environmental resistome builds up which can lead to wider dissemination of resistant bacteria [84]. The presence of antibiotics in foods consumed by humans has its own implications on antibiotic resistance development by the human gut microbiome [85]. The connection between antibiotic use and resistance development was first observed in E. coli isolated from the gut of chickens fed with streptomycin [86]. Some of the important pathogens of particular consideration with respect to their development of resistance to the above three classes of drugs include Clostridium difficile, Campylobacter, Salmonella, Shigella, and S. aureus. Currently, several antimicrobials of human medical use are being used in livestock, poultry, and aquaculture (Table 2). Some of these such as the fluoroquinolones are critical for the treatment of Gram-negative infections in humans, and their use in food animals may jeopardize the efficacy of these antibiotics due to the development of resistance in pathogens of zoonotic potential [87]. Scientifically based investigations suggest a strong relationship between antibiotic use in food animals and the development of antibiotic resistance by bacteria associated with farm animals [88,89,90]. There are numerous documented instances in which the introduction of an antibiotic as an AGP or for the treatment of specific infections resulted in the emergence of antibiotic-resistant bacterial variants [91]. Food animals and workers on farms using AGPs harbor more antibiotic-resistant bacteria compared to those from farms not using AGPs [92]. Antibiotic-resistant bacteria associated with food animals has resulted in their dissemination via the food chain and into the environment, and in farm workers being the carriers of such bacteria [81,93]. A study in the USA revealed that poultry workers had a 32-times-higher risk of carrying gentamicin-resistant E. coli compared with community referents [94]. It has been experimentally shown that the use of avoparcin in chicks resulted in the development of vancomycin resistance by Enterococcus faecium (VRE), and such bacteria could be transmitted to humans via their consumption of meat contaminated with VRE [74]. Prohibition of avoparcin in European Union countries in 1997 resulted in a decrease of VRE in poultry and in the community [95]. The decrease in the use of tylosin during 1998 and 1999 was followed by a decrease in erythromycin resistance among E. faecium and E. faecalis isolates from pigs [96]. An increased occurrence of virginiamycin resistance among E. faecium isolates in broilers correlated with the increased use of virginiamycin during 1995 to 1997 in Denmark, and the subsequent ban on the use of virginiamycin in 1998 resulted in a decrease in the resistance [96]. A strong correlation between the use of sub-therapeutic concentrations of tetracycline, alone or in combination with sulfamethazine, and the carriage of resistant strains of Campylobacter species in feedlot cattle has been demonstrated [97]. Quinolonesand third and fourth generation cephalosporins are important in treating salmonellosis in humans, and their widespread use in animal husbandry has selected for resistant strains that can potentially jeopardize their human clinical application [98]. A surveillance study in the USA revealed a strong association between the rise in ciprofloxacin resistance in Campylobacter spp. and the use of fluoroquinolones such as sarafloxacin and enrofloxacin in food-producing animals [99]. A sharp rise in ciprofloxacin resistance in Campylobacter as a result of the use of fluoroquinolones in food-producing animals has been reported from Denmark, Spain and the Netherlands [88,100]. The introduction of fluoroquinolones for the treatment of respiratory diseases led to the emergence of fluoroquinolone-resistant Campylobacter [88,101]. The use of third generation cephalosporins led to an increase in the number of cephalosporin-resistant Salmonella strains [102]. A study by Alexander et al. [103] has shown that sub-therapeutic administration of tetracycline in combination with sulfamethazine increased the prevalence of tetracycline- and AMP-resistant E. coli in cattle. The development of multidrug resistance in E. coli and Salmonella in swine fed with antimicrobial feed has been reported by several investigators [104,105,106,107]. Similarly, it has been reported that macrolides, which are widely used in food animals, result in the selection of macrolide-resistant Campylobacter spp. [98]. Considering the importance of macrolides in the treatment of Campylobacter infections in children, its use in food animals requires critical rethinking. Another serious pathogen associated with livestock and which poses the danger of transmission via food-producing animals is the methicillin-resistant Staphylococcus aureus (MRSA). A particular sequence type, ST398, of livestock-associated MRSA (LA-MRSA) has also been found in farm facilities and in farm workers [108]. However, there is no evidence to directly link human infections of LA-MRSA to their livestock origin. Historically, when antimicrobial agents were first used in agriculture, such as in food production environments, bacterial multidrug-resistant variants of S. enterica and E. coli soon emerged [109,110]. Shortly after the emergence of this multidrug resistance occurred, transfer of the resistance determinants was detected in the form of plasmids, thus facilitating their movement from food animals to humans and the subsequent transmission to the gastrointestinal tract of new human hosts [91,111]. Together, mobile genetic transfer elements (e.g., bacteriophages, plasmids, gene cassettes, integrons, transposons) and various modes of infection transmission (e.g., direct food animal to human and food-borne) have facilitated the spread of newly emerged resistance determinants from food animals and their food products to humans and their communities, as a consequence of exposure to sub-lethal concentrations of antimicrobial agents [112,113]. These sub-inhibitory concentrations of antimicrobial agents used in agriculture exert selective evolutionary pressures upon the populations of bacteria that reside in food production environments, resulting in the emergence and subsequent predominance of multidrug-resistant variants [52,114]. Such multidrug-resistant variants have included Gram-positive and –negative bacteria such as Enterococcus spp. [115], Lactococcus spp. [116], Lactobacillus spp. [117], S. aureus [118], and Gram-negative bacteria such as E. coli [119], Campylobacter spp. [120], Listeria monocytogenes [121] and S. enterica [54,122]. Consequently, it has since been widely documented that antimicrobial use in food animals correlates not only with the emergence of bacterial multidrug resistance but also with the spread of infectious diseases that are recalcitrant to efficacious chemotherapy in humans [92,114,123,124]. Policy practices implemented in Europe in which antimicrobial non-therapeutic uses are completely banned (e.g., avoparcin and virginiamycin) in agriculture settings have resulted in reductions in both the prevalence of multidrug-resistant pathogens and in the minimal inhibitory concentrations (MICs) for clinically relevant antimicrobials, such as vancomycin [92,124]. Despite the extensive amount of work over a span of 50 years definitively demonstrating an association between antimicrobial agents and the incidence and prevalence of multiple drug-resistant microorganisms in food production circles [125], the issue remains surprisingly controversial in agriculture, but apparently not in human healthcare settings. Therefore, with respect to antimicrobial usage in agriculture, more work will be necessary to gain a fuller understanding of the nature and extent of the resistance prevalence problem, the overall efficacy of the antimicrobial bans, and the resulting improvement in human health [92]. A review study by the European Food Safety Authority (EFSA) and the European Medicines Agency (EMA) on the impact of measures taken to reduce the use of antimicrobials in food-producing animals on the occurrence of antimicrobial resistance (AMR) in bacteria from food-producing animals suggested an association between the reduction in antimicrobial use and reduced AMR [126], although a multiplicity of factors contribute to AMR development. An integrated approach involving different stakeholders to reduce the use of antimicrobials in animals has been recommended, which emphasizes better management practices to reduce the risks of disease, searching for alternative strategies such as competitive exclusion of pathogens, immunostimulants, probiotics, and bacteriophages, and avoiding the preventive use of antimicrobials, etc. [126].
What the sources say
- Not checked yetcites [52] Andersen, 2015, Multidrug efflux pumps from Enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus bacterial food pathogens, Int. J. Environ. Res. Public Health source
- Not checked yetcites [114] Witte, 2000, Selective pressure by antibiotic use in livestock, Int. J. Antimicrob. Agents source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The use of antibiotics for short-term gains has inflicted a long-lasting negative impact on human health and in the environment [14].”
§ The Food Production Environment and the Development of Antimicrobial Resistance in Human Pathogens of Animal Origin > 1. Introduction
What the sources say
- Not checked yetcites [14] Chattopadhyay, 2014, Use of antibiotics as feed additives: A burning question, Front. Microbiol. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In the United States, nearly 80% of the antibiotics produced are used in animal husbandry [11].”
§ The Food Production Environment and the Development of Antimicrobial Resistance in Human Pathogens of Animal Origin > 1. Introduction
What the sources say
- Not checked yetcites [11] United States Food and Drug Administration (2014). Summary Report on Antimicrobials Sold or Distributed for Use in Food-Producing Animals, United States Food and Drug Administration.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Indiscriminate use of antibiotics for purposes other than treatment of infections has resulted in the emergence of antibiotic-resistant pathogens in food production environments, and such pathogens can cause infections in humans that are difficult to treat or control.”
§ The Food Production Environment and the Development of Antimicrobial Resistance in Human Pathogens of Animal Origin > 1. Introduction
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
21 more claims
Create a free account to see all 38 claims and to verify the 37 references still open.
- It may state two separate claims as one. 10
- Probably not a substantial claim. 3
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Antibiotics that have been used in the management of cholera cases for decades such as tetracyclines, which include doxycycline and tetracycline, have been associated with the presence of IncC conjugative plasmids.15,16,17”
From Geographical distribution and antibiotics susceptibility patterns of toxigenic Vibrio cholerae isolates from Kisumu County, Kenya (2020) · cites this paper as [16]
Citations
Cites
Origins and evolution of antibiotic resistance
Davies, J., & Davies, D. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00016-10 · Cited by 5,784 · cited 1×
“However, bacterial pathogens soon exhibited the signs of surviving the lethal effects of antimicrobials, and the first penicillin-resistant Staphylococcus was reported soon after the introduction of penicillin in 1946, although penicillinases were discovered considerably before the discovery of penicillin itself, sugg…”
BackgroundAntibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Global trends in antimicrobial use in food animals
Van Boeckel, T. P., Brower, C., Gilbert, M., Grenfell, B. T., Levin, S. A., Robinson, T. P., Teillant, A., & Laxminarayan, R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1503141112 · Cited by 3,973 · cited 2×
“Global antimicrobial use in food animals (a) Major users of antimicrobials in livestock in 2010; (b) Major users of antimicrobials in livestock in 2030 (projected) [65].”
BackgroundFood Animals and Antimicrobials: Impacts on Human Health
Marshall, B. M., & Levy, S. B. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00002-11 · Cited by 2,241 · cited 7×
“Considering the potential link between the use of antibiotics and their effect on human health, the World Health Organization (WHO) recommended the termination of AGPs belonging to classes of antibiotics used in human treatment and cautious application of other AGPs with routine monitoring of resistance development [1…”
BackgroundInfluentialMobile genetic elements: the agents of open source evolution
Frost, L. S., Leplae, R., Summers, A. O., & Toussaint, A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1235 · Cited by 1,847 · cited 1×
“, direct food animal to human and food-borne) have facilitated the spread of newly emerged resistance determinants from food animals and their food products to humans and their communities, as a consequence of exposure to sub-lethal concentrations of antimicrobial agents [112,113].”
BackgroundOuter membrane permeability and antibiotic resistance
Delcour, A. H. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.11.005 · Cited by 1,762 · cited 1×
“This mechanism is referred to as drug permeability reduction and prevents access of antimicrobial agents to their intracellular drug targets, thus conferring antimicrobial resistance [35,36].”
BackgroundMechanisms of Antimicrobial Resistance in Bacteria
Tenover, F. C. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.011 · Cited by 1,682
A brief history of the antibiotic era: lessons learned and challenges for the future
Aminov, R. I. (2010) · Frontiers in Microbiology · doi:10.3389/fmicb.2010.00134 · Cited by 1,628 · cited 1×
“Infectious diseases were thought to have been controlled, and the magic of antibiotics continued for a specific period of time during the mid-20th century, called the “golden era of antibiotic chemotherapy” [2].”
BackgroundThe Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614 · cited 2×
“Bacteria harboring these determinants are essentially resistant to clinically important antimicrobials such as the aminoglycosides, the β-lactams, the fluoroquinolones and the chloramphenicols [37].”
BackgroundSampling the Antibiotic Resistome
D'Costa, V. M., McGrann, K. M., Hughes, D. W., & Wright, G. D. (2006) · Science · doi:10.1126/science.1120800 · Cited by 1,594 · cited 1×
“However, bacterial pathogens soon exhibited the signs of surviving the lethal effects of antimicrobials, and the first penicillin-resistant Staphylococcus was reported soon after the introduction of penicillin in 1946, although penicillinases were discovered considerably before the discovery of penicillin itself, sugg…”
BackgroundAminoglycoside modifying enzymes
Ramirez, M. S., & Tolmasky, M. E. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.08.003 · Cited by 1,464
Platforms for antibiotic discovery
Lewis, K. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3975 · Cited by 1,445 · cited 1×
“The discovery of several antimicrobials soon followed, such as sulfanilamide (1932) [58], streptomycin (1942) [59], bacitracin (an aminoglycoside) (1945), chloramphenicol (phenicols) (1947), chlortetracycline (tetracyclines) (1948), erythromycin (macrolide) (1952), vancomycin (glycopeptides) (1953), cycloserine (1955)…”
BackgroundSchatz, A., Bugle, E., & Waksman, S. A. (1944) · Experimental Biology and Medicine · doi:10.3181/00379727-55-14461 · Cited by 1,150 · cited 1×
“The discovery of several antimicrobials soon followed, such as sulfanilamide (1932) [58], streptomycin (1942) [59], bacitracin (an aminoglycoside) (1945), chloramphenicol (phenicols) (1947), chlortetracycline (tetracyclines) (1948), erythromycin (macrolide) (1952), vancomycin (glycopeptides) (1953), cycloserine (1955)…”
BackgroundLeclercq, R. (2002) · Clinical Infectious Diseases · doi:10.1086/324626 · Cited by 1,102 · cited 1×
“Other hydrolytic enzymes include esterases, which inactivate certain macrolide antimicrobials [20,21].”
Phillips, I. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg483 · Cited by 1,100 · cited 1×
“Although the actual impact of the effect of antimicrobial use and the resultant resistance development by human pathogenic bacteria is a topic of intense debate [127,128], the worldwide concern of the rapid emergence of antibiotic resistance in human pathogens has led to the banning of antimicrobial use for growth pro…”
BackgroundOrigins and evolution of antibiotic resistance.
DAVIES, J. E. (1996) · PubMed · Cited by 1,033
Antimicrobial Use and Resistance in Animals
McEwen, S. A., & Fedorka‐Cray, P. J. (2002) · Clinical Infectious Diseases · doi:10.1086/340246 · Cited by 983
Medical consequences of antibiotic use in agriculture
Witte, W. (1998) · Science · doi:10.1126/science.279.5353.996 · Cited by 940 · cited 1×
“The use of low-dose, sub-therapeutic concentrations in animal systems results in the selection of a resistant population of bacteria which colonize the animal surface, the gut and the rearing environment [81,82].”
BackgroundCabello, F. C., Godfrey, H. P., Tomova, A., Ivanova, L., Dölz, H., Millanao, A., & Buschmann, A. H. (2013) · Environmental Microbiology · doi:10.1111/1462-2920.12134 · Cited by 898 · cited 1×
“The presence of antibiotics in foods consumed by humans has its own implications on antibiotic resistance development by the human gut microbiome [85].”
BackgroundThe Challenge of Antibiotic Resistance
Levy, S. B. (1998) · Scientific American · doi:10.1038/scientificamerican0398-46 · Cited by 867
Mechanisms of drug resistance: quinolone resistance
Hooper, D. C., & Jacoby, G. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12830 · Cited by 716 · cited 1×
“A well-known example of this type of resistance mechanism includes those determinants for quinolone and fluoroquinolone resistances in which DNA gyrase, the target for these antimicrobials, is subtly altered, often by point mutation, such that the antimicrobials cannot bind to these target variants [28].”
BackgroundButaye, P., Devriese, L. A., & Haesebrouck, F. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.2.175-188.2003 · Cited by 712 · cited 2×
“Antibiotics used for growth promotion and feed efficiency in food animals [64].”
BackgroundEngberg, J., Aarestrup, F. M., Taylor, D. E., Gerner-Smidt, P., & Nachamkin, I. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0701.010104 · Cited by 696 · cited 1×
“A sharp rise in ciprofloxacin resistance in Campylobacter as a result of the use of fluoroquinolones in food-producing animals has been reported from Denmark, Spain and the Netherlands [88,100].”
BackgroundRoberts, M. C. (1996) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.1996.tb00251.x · Cited by 689 · cited 1×
“A well-studied bacterial mechanism of this type includes resistance to the tetracyclines, a class of protein synthesis inhibitors that bind to the 30S subunit of the ribosome, in which the tetracycline binding site on the ribosome is protected by small peptides that prevent the antibiotic from binding to its target [3…”
BackgroundFunctionality of enterococci in dairy products
Giraffa, G. (2003) · International Journal of Food Microbiology · doi:10.1016/s0168-1605(03)00183-1 · Cited by 681
Quinolone-Resistant Campylobacter jejuni Infections in Minnesota, 1992–1998
Smith, K. E., Besser, J. M., Hedberg, C. W., Leano, F. T., Bender, J. B., Wicklund, J. H., Johnson, B. P., Moore, K. A., & Osterholm, M. T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905203402001 · Cited by 666
Aarestrup, F. M., Seyfarth, A. M., Emborg, H.-D., Pedersen, K., Hendriksen, R. S., & Bager, F. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.2054-2059.2001 · Cited by 652 · cited 1×
“faecium isolates in broilers correlated with the increased use of virginiamycin during 1995 to 1997 in Denmark, and the subsequent ban on the use of virginiamycin in 1998 resulted in a decrease in the resistance [96].”
BackgroundMechanisms of antimicrobial resistance in bacteria
Tenover, F. C. (2006) · American Journal of Infection Control · doi:10.1016/j.ajic.2006.05.219 · Cited by 637
The Scourge of Antibiotic Resistance: The Important Role of the Environment
Finley, R. L., Collignon, P., Larsson, D. G. J., McEwen, S. A., Li, X.-Z., Gaze, W. H., Reid-Smith, R., Timinouni, M., Graham, D. W., & Topp, E. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit355 · Cited by 636 · cited 1×
“An environmental resistome builds up which can lead to wider dissemination of resistant bacteria [84].”
BackgroundIndustrial Food Animal Production, Antimicrobial Resistance, and Human Health
Silbergeld, E. K., Graham, J., & Price, L. B. (2008) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.29.020907.090904 · Cited by 635 · cited 2×
“Consequently, it has since been widely documented that antimicrobial use in food animals correlates not only with the emergence of bacterial multidrug resistance but also with the spread of infectious diseases that are recalcitrant to efficacious chemotherapy in humans [92,114,123,124].”
BackgroundChantziaras, I., Boyen, F., Callens, B., & Dewulf, J. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt443 · Cited by 622 · cited 1×
“coli isolates towards those antibiotics in pigs, poultry and cattle [80].”
BackgroundFleming, A. (1980) · Clinical Infectious Diseases · doi:10.1093/clinids/2.1.129 · Cited by 612 · cited 1×
“The discovery of the first antibiotic penicillin in 1929 by Alexander Fleming paved the way for the modern antibiotic era [57].”
BackgroundExploiting bacterial DNA gyrase as a drug target: current state and perspectives
Collin, F., Karkare, S., & Maxwell, A. (2011) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3557-z · Cited by 606 · cited 1×
“Extensively studied bacterial targets include cellular machinery for the synthesis of proteins, such as the ribosome [24], as well as the syntheses of bacterial cell walls, such as transpeptidases [25], or of nucleic acids, such as DNA gyrase [26] and RNA polymerase [27].”
BackgroundEndtz, H. P., Ruijs, G. J., van Klingeren, B., Jansen, W. H., van der Reyden, T., & Mouton, R. P. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/27.2.199 · Cited by 590 · cited 9×
“Such multidrug-resistant variants have included Gram-positive and –negative bacteria such as Enterococcus spp. [115], Lactococcus spp. [116], Lactobacillus spp. [117], S. aureus [118], and Gram-negative bacteria such as E. coli [119], Campylobacter spp. [120], Listeria monocytogenes [121] and S. enterica [54,122].”
BackgroundInfluentialAntibiotics in agriculture and the risk to human health: how worried should we be?
Chang, Q., Wang, W., Regev‐Yochay, G., Lipsitch, M., & Hanage, W. P. (2015) · Evolutionary Applications · doi:10.1111/eva.12185 · Cited by 562 · cited 1×
“The use of antimicrobials in animal husbandry and the resultant development of antibiotic resistance in bacteria is recognized as a potential human health concern for various reasons, such as: (i) the antibiotic-resistant bacteria associated with animals may be pathogenic to humans; (ii) antibiotic-resistant bacteria…”
BackgroundSusceptibility of Lactobacillus spp. to antimicrobial agents
Danielsen, M., & Wind, A. (2003) · International Journal of Food Microbiology · doi:10.1016/s0168-1605(02)00254-4 · Cited by 559
Human Health Consequences of Use of Antimicrobial Agents in Aquaculture
Heuer, O. E., Kruse, H., Grave, K., Collignon, P., Karunasagar, I., & Angulo, F. J. (2009) · Clinical Infectious Diseases · doi:10.1086/605667 · Cited by 533 · cited 1×
“Human infections by such resistant bacteria become either untreatable or the treatment becomes prolonged, complicated and expensive [13].”
BackgroundAntibiotics in animal feed and their role in resistance development
Wegener, H. C. (2003) · Current Opinion in Microbiology · doi:10.1016/j.mib.2003.09.009 · Cited by 517 · cited 1×
“It is now well established that the use of antibiotics in livestock and aquaculture results in the development of resistance in human pathogens directly or indirectly, as susceptible bacteria die, leaving behind resistant variants which in turn predominate [12].”
BackgroundActive efflux mechanisms for antimicrobial resistance
Levy, S. B. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.4.695 · Cited by 503 · cited 1×
“The efflux of multiple antimicrobials from the intracellular location of the bacterium effectively reduces the drug concentrations and confers resistance to antimicrobials [40,41].”
BackgroundTetracyclines: Antibiotic action, uptake, and resistance mechanisms
Schnappinger, D., & Hillen, W. (1996) · Archives of Microbiology · doi:10.1007/s002030050339 · Cited by 484 · cited 1×
“A well-studied bacterial mechanism of this type includes resistance to the tetracyclines, a class of protein synthesis inhibitors that bind to the 30S subunit of the ribosome, in which the tetracycline binding site on the ribosome is protected by small peptides that prevent the antibiotic from binding to its target [3…”
BackgroundMaron, D. F., Smith, T. J., & Nachman, K. E. (2013) · Globalization and Health · doi:10.1186/1744-8603-9-48 · Cited by 481
Bager, F., Madsen, M., Christensen, J., & Aarestrup, F. M. (1997) · Preventive Veterinary Medicine · doi:10.1016/s0167-5877(96)01119-1 · Cited by 426
Bacterial resistance to antibiotics: Modified target sites
LAMBERT, P. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.04.003 · Cited by 424 · cited 1×
“Such drug resistance mechanisms are referred to as target alteration or modification [23].”
BackgroundResistance in bacteria of the food chain: Epidemiology and control strategies
Aarestrup, F. M., Wegener, H. C., & Collignon, P. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.5.733 · Cited by 406 · cited 2×
“The use of low-dose, sub-therapeutic concentrations in animal systems results in the selection of a resistant population of bacteria which colonize the animal surface, the gut and the rearing environment [81,82].”
BackgroundActive efflux, a common mechanism for biocide and antibiotic resistance
Levy, S. B. (2002) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.92.5s1.4.x · Cited by 401 · cited 1×
“The efflux of multiple antimicrobials from the intracellular location of the bacterium effectively reduces the drug concentrations and confers resistance to antimicrobials [40,41].”
BackgroundNelson, J. M., Chiller, T. M., Powers, J. H., & Angulo, F. J. (2007) · Clinical Infectious Diseases · doi:10.1086/512369 · Cited by 397 · cited 9×
“Such multidrug-resistant variants have included Gram-positive and –negative bacteria such as Enterococcus spp. [115], Lactococcus spp. [116], Lactobacillus spp. [117], S. aureus [118], and Gram-negative bacteria such as E. coli [119], Campylobacter spp. [120], Listeria monocytogenes [121] and S. enterica [54,122].”
BackgroundInfluentialMultidrug efflux transporters in the MATE family
Kuroda, T., & Tsuchiya, T. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.11.012 · Cited by 396 · cited 1×
“Secondary active transport systems use ion gradients generated by respiration as the driving energy force required for active drug efflux [44,45], and include the resistance-nodulation-cell division (RND) superfamily [46], the small multidrug resistance (SMR) superfamily [47], the multidrug and toxic compound extrusio…”
BackgroundBenefits and risks of antimicrobial use in food-producing animals
Hao, H., Cheng, G., Iqbal, Z., Ai, X., Hussain, H. I., Huang, L., Dai, M., Wang, Y., Liu, Z., & Yuan, Z. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00288 · Cited by 383 · cited 2×
“Seve al stud es have sugg sted that the use of antibiotic growth promoters has positive effects on the overall growth and well-being of food animals subjected to intensive farming practices [71].”
BackgroundLevy, S. B., FitzGerald, G. B., & Macone, A. B. (1976) · New England Journal of Medicine · doi:10.1056/nejm197609092951103 · Cited by 352 · cited 1×
“There are numerous documented instances in which the introduction of an antibiotic as an AGP or for the treatment of specific infections resulted in the emergence of antibiotic-resistant bacterial variants [91].”
BackgroundThe Antibiotic Paradox: How Miracle Drugs Are Destroying the Miracle
Levy, S. B. (1992) · Springer eBooks · doi:10.1007/978-1-4899-6042-9 · Cited by 337
Spread of antibiotic-resistant plasmids from chicken to chicken and from chicken to man
LEVY, S. B., FITZGERALD, G. B., & MACONE, A. B. (1976) · Nature · doi:10.1038/260040a0 · Cited by 324
Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria
Nikaido, H. (2001) · Seminars in Cell & Developmental Biology · doi:10.1006/scdb.2000.0247 · Cited by 317 · cited 3×
“Alternatively, additional elements in the cell walls may function in synergy with the outer membrane proteins to mediate the active efflux of multiple antimicrobials, a system that is known as a multipartite complex consisting of the outer membrane protein, a periplasmic membrane fusion protein, and an inner membrane…”
BackgroundUse of antibiotics as feed additives: a burning question
Chattopadhyay, M. K. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00334 · Cited by 316 · cited 1×
“The use of antibiotics for short-term gains has inflicted a long-lasting negative impact on human health and in the environment [14].”
BackgroundSelective pressure by antibiotic use in livestock
Witte, W. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00301-0 · Cited by 315 · cited 2×
“Consequently, it has since been widely documented that antimicrobial use in food animals correlates not only with the emergence of bacterial multidrug resistance but also with the spread of infectious diseases that are recalcitrant to efficacious chemotherapy in humans [92,114,123,124].”
BackgroundMultidrug resistant commensal Escherichia coli in animals and its impact for public health
Szmolka, A., & Nagy, B. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00258 · Cited by 314
EMA Committee for Medicinal Products for Veterinary Use (CVMP) and EFSA Panel on Biological Hazards (BIOHAZ), Murphy, D., Ricci, A., Auce, Z., Beechinor, J. G., Bergendahl, H., Breathnach, R., Bureš, J., Duarte Da Silva, J. P., Hederová, J., et al. (2017) · EFSA Journal · doi:10.2903/j.efsa.2017.4666 · Cited by 314
Schatz, A., Bugie, E., Waksman, S. A., Hanssen, A. D., Patel, R., & Osmon, D. R. (2005) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000175887.98112.fe · Cited by 305
Klare, I., BADSTÜBNER, D., Konstabel, C., BÖHME, G., Claus, H., & Witte, W. (1999) · Microbial Drug Resistance · doi:10.1089/mdr.1999.5.45 · Cited by 304 · cited 1×
“Prohibition of avoparcin in European Union countries in 1997 resulted in a decrease of VRE in poultry and in the community [95].”
BackgroundAntimicrobial Resistance among Campylobacter Strains, United States, 1997–2001
Gupta, A., Nelson, J. M., Barrett, T. J., Tauxe, R. V., Rossiter, S. P., Friedman, C. R., Joyce, K. W., Smith, K. E., Jones, T. F., Hawkins, M. A., et al. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1006.030635 · Cited by 269 · cited 1×
“and the use of fluoroquinolones such as sarafloxacin and enrofloxacin in food-producing animals [99].”
BackgroundWegener, H. C., Aarestrup, F. M., Jensen, L. B., Hammerum, A. M., & Bager, F. (1999) · Emerging Infectious Diseases · doi:10.3201/eid0503.990303 · Cited by 265 · cited 3×
“Prohibition of avoparcin in European Union countries in 1997 resulted in a decrease of VRE in poultry and in the community [95].”
BackgroundSalmonella infections: An update on epidemiology, management, and prevention
Sánchez-Vargas, F. M., Abu-El-Haija, M. A., & Gómez-Duarte, O. G. (2011) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2011.11.001 · Cited by 264
Evolutionary origins of multidrug and drug‐specific efflux pumps in bacteria
Saier, M. H., Paulsen, I. T., Marek, K. S., Pao, S. S., Ronald, A. S., & Nikaido, H. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.03.265 · Cited by 263 · cited 1×
“These resistance mechanisms involve several major and large classes of transporter protein superfamilies [42].”
BackgroundTampa, M. Ş., Sârbu, M. I., Matei, C. O., Benea, V., & Georgescu, S. R. (2014) · Europe PMC (PubMed Central) · Cited by 259
Wierup, M. (2001) · Microbial Drug Resistance · doi:10.1089/10766290152045066 · Cited by 253 · cited 1×
“Denmark and Sweden were the first to implement regulations on antibiotic use in animals and their experiences have shown positive impacts on the reduction of antimicrobial resistance in bacteria with minimum economic implications to the industry [132].”
BackgroundSmet, A., Martel, A., Persoons, D., Dewulf, J., Heyndrickx, M., Herman, L., Haesebrouck, F., & Butaye, P. (2010) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2009.00198.x · Cited by 241 · cited 1×
“constitute a significant challenge both in the agricultural as well as in the human and veterinarian clinical settings [19].”
BackgroundImpact of antibiotic use in the swine industry
Barton, M. D. (2014) · Current Opinion in Microbiology · doi:10.1016/j.mib.2014.05.017 · Cited by 233 · cited 2×
“Over the last four decades, several antibiotics have been employed in animals for three main purposes: treatment of infections (therapeutic use), prevention of disease outbreaks in animals (prophylaxis) and growth promotion [67].”
BackgroundThe impact of feed additives on the microbial ecology of the gut in young pigs
Jensen, B. (1998) · Journal of Animal and Feed Sciences · doi:10.22358/jafs/69955/1998 · Cited by 229
Secondary solute transport in bacteria
Poolman, B., & Konings, W. N. (1993) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(93)90003-x · Cited by 192
LmrS Is a Multidrug Efflux Pump of the Major Facilitator Superfamily from Staphylococcus aureus
Floyd, J. L., Smith, K. P., Kumar, S. H., Floyd, J. T., & Varela, M. F. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00580-10 · Cited by 188 · cited 1×
“Secondary active transport systems use ion gradients generated by respiration as the driving energy force required for active drug efflux [44,45], and include the resistance-nodulation-cell division (RND) superfamily [46], the small multidrug resistance (SMR) superfamily [47], the multidrug and toxic compound extrusio…”
BackgroundSelf-citationThe use and resistance to antibiotics in the community
Čižman, M. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(02)00394-1 · Cited by 188 · cited 1×
“In the clinical settings, inappropriate use accounts for 20%–50% of the antibiotics consumed [6].”
BackgroundThe emergence of clinical resistance to tigecycline
Sun, Y., Cai, Y., Liu, X., Bai, N., Liang, B., & Wang, R. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.09.005 · Cited by 185 · cited 1×
“A newer synthetic derivative of the tetracyclines, a glycylcycline called tigecycline, overcomes the effects of this protection mechanism [32], an effect that is unfortunately reversed by active drug efflux transporters that confer tigecycline resistance [33].”
BackgroundABC transporters: how small machines do a big job
Davidson, A. L., & Maloney, P. C. (2007) · Trends in Microbiology · doi:10.1016/j.tim.2007.09.005 · Cited by 180 · cited 1×
“The ATP-binding cassette (ABC) transporters use the biological energy of ATP hydrolysis to mediate the extrusion of antimicrobial agents from the bacterial cell [43].”
BackgroundDhama, K., Karthik, K., Tiwari, R., Shabbir, M. Z., Barbuddhe, S., Malik, S. V. S., & Singh, R. K. (2015) · Veterinary Quarterly · doi:10.1080/01652176.2015.1063023 · Cited by 174 · cited 1×
“[120], Listeria monocytogenes [121] and S.”
Drug Resistance in Salmonella Typhimurium and its Implications
Anderson, E. S. (1968) · BMJ · doi:10.1136/bmj.3.5614.333 · Cited by 172
Tigecycline: A glycylcycline antimicrobial agent
Doan, T.-L., Fung, H. B., Mehta, D., & Riska, P. F. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.08.011 · Cited by 171 · cited 1×
“A newer synthetic derivative of the tetracyclines, a glycylcycline called tigecycline, overcomes the effects of this protection mechanism [32], an effect that is unfortunately reversed by active drug efflux transporters that confer tigecycline resistance [33].”
BackgroundAndersen, J., He, G.-X., Kakarla, P., KC, R., Kumar, S., Lakra, W., Mukherjee, M., Ranaweera, I., Shrestha, U., Tran, T., et al. (2015) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph120201487 · Cited by 167 · cited 2×
“Secondary active transport systems use ion gradients generated by respiration as the driving energy force required for active drug efflux [44,45], and include the resistance-nodulation-cell division (RND) superfamily [46], the small multidrug resistance (SMR) superfamily [47], the multidrug and toxic compound extrusio…”
BackgroundSelf-citationModulation of Bacterial Multidrug Resistance Efflux Pumps of the Major Facilitator Superfamily
Kumar, S., Mukherjee, M. M., & Varela, M. F. (2013) · International Journal of Bacteriology · doi:10.1155/2013/204141 · Cited by 166 · cited 1×
“Although the crystal structures have been solved for only a few key multidrug efflux pumps [50], these MFS multidrug efflux pumps make good targets for modulation, such as inhibition [55,56], in order to restore the clinical efficacy”
BackgroundSelf-citationThe residues and environmental risks of multiple veterinary antibiotics in animal faeces
Li, Y.-X., Zhang, X.-L., Li, W., Lu, X.-F., Liu, B., & Wang, J. (2013) · Environmental Monitoring and Assessment · doi:10.1007/s10661-012-2702-1 · Cited by 156 · cited 1×
“Since a substantial quantity of antimicrobials is excreted by the animals via feces, environmental contamination with sub-lethal concentrations of antimicrobials occurs [83].”
BackgroundHealy, V. L., Lessard, I. A. D., Roper, D. I., Knox, J. R., & Walsh, C. T. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00116-2 · Cited by 150 · cited 1×
“Extensively studied bacterial targets include cellular machinery for the synthesis of proteins, such as the ribosome [24], as well as the syntheses of bacterial cell walls, such as transpeptidases [25], or of nucleic acids, such as DNA gyrase [26] and RNA polymerase [27].”
BackgroundAlexander, T. W., Yanke, L. J., Topp, E., Olson, M. E., Read, R. R., Morck, D. W., & McAllister, T. A. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.00489-08 · Cited by 145 · cited 1×
“[103] has shown that sub-therapeutic administration of tetracycline in combination with sulfamethazine increased the prevalence of tetracycline- and AMP-resistant E.”
BackgroundBortolaia, V., Espinosa‐Gongora, C., & Guardabassi, L. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.12.003 · Cited by 143 · cited 1×
“aureus [118], and Gram-negative bacteria such as E.”
BackgroundBiochemistry of Bacterial Multidrug Efflux Pumps
Kumar, S. H., & Varela, M. F. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13044484 · Cited by 140 · cited 1×
“The last bacterial mechanism considered here involves the active efflux of antimicrobial agents from the bacterial cell, where most, if not all, of the drug targets reside [38,39].”
BackgroundSelf-citationRND Efflux Pumps: Structural Information Translated into Function and Inhibition Mechanisms
Ruggerone, P., Murakami, S., M. Pos, K., & Vargiu, A. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/15680266113136660220 · Cited by 140 · cited 1×
“Secondary active transport systems use ion gradients generated by respiration as the driving energy force required for active drug efflux [44,45], and include the resistance-nodulation-cell division (RND) superfamily [46], the small multidrug resistance (SMR) superfamily [47], the multidrug and toxic compound extrusio…”
BackgroundMacrolides and lincosamides in cattle and pigs: Use and development of antimicrobial resistance
Pyörälä, S., Baptiste, K. E., Catry, B., van Duijkeren, E., Greko, C., Moreno, M. A., Pomba, M. C. M. F., Rantala, M., Ružauskas, M., Sanders, P., et al. (2014) · The Veterinary Journal · doi:10.1016/j.tvjl.2014.02.028 · Cited by 138 · cited 1×
“Other hydrolytic enzymes include esterases, which inactivate certain macrolide antimicrobials [20,21].”
BackgroundOral antimicrobials increase antimicrobial resistance in porcine E. coli – A systematic review
Burow, E., Simoneit, C., Tenhagen, B., & Käsbohrer, A. (2014) · Preventive Veterinary Medicine · doi:10.1016/j.prevetmed.2013.12.007 · Cited by 137
Stutz, M. W., & LAWTON, G. C. (1984) · Poultry Science · doi:10.3382/ps.0632036 · Cited by 136 · cited 1×
“In chickens, the use of antimicrobials, such as bacitracin, penicillin, chlortetracycline, oxytetracycline, erythromycin, tylosin, virginiamycin, lincomycin, bambermycin and carbadox improved weight gain and feed efficiency in broiler chicks [73].”
BackgroundQuinolone resistance in the food chain
Fàbrega, A., Sánchez‐Céspedes, J., Soto, S. M., & Vilà, J. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.12.010 · Cited by 131
Epidemiology of antimicrobial resistance in enterococci of animal origin
Hershberger, E., Oprea, S. F., Donabedian, S. M., Perri, M. B., Bozigar, P. S., Bartlett, P. C., & Zervos, M. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh508 · Cited by 130 · cited 1×
“Consequently, it has since been widely documented that antimicrobial use in food animals correlates not only with the emergence of bacterial multidrug resistance but also with the spread of infectious diseases that are recalcitrant to efficacious chemotherapy in humans [92,114,123,124].”
BackgroundGenetic Linkage and Horizontal Gene Transfer, the Roots of the AntibioticMulti-Resistance Problem
Summers, A. O. (2006) · Animal Biotechnology · doi:10.1080/10495390600957217 · Cited by 126 · cited 1×
“, direct food animal to human and food-borne) have facilitated the spread of newly emerged resistance determinants from food animals and their food products to humans and their communities, as a consequence of exposure to sub-lethal concentrations of antimicrobial agents [112,113].”
BackgroundNUTRITIONAL EFFECTS OF ANTIBIOTICS
JUKES, T. H., & WILLIAMS, W. L. (1953) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07332-6 · Cited by 120 · cited 1×
“The positive effect of antibiotics on growth was first observed in chickens that were fed with fermentation by-products of the tetracycline-producing Streptomyces aureofaciens bacterium in the 1940s [61].”
BackgroundMolecular mechanisms of bacterial resistance to antimicrobial agents
Kumar, S. H., & Varela, M. F. (2013) · Cited by 116
Self-citationSMR-type multidrug resistance pumps.
Chung, Y. J., & Saier, M. H. (2001) · PubMed · Cited by 112
del Rio, J. R. M. (1945) · PubMed · Cited by 110
Dunlop, R. H., McEwen, S. A., Meek, A. H., Clarke, R. C., Black, W. D., & Friendship, R. M. (1998) · Preventive Veterinary Medicine · doi:10.1016/s0167-5877(97)00095-0 · Cited by 109 · cited 4×
“The WHO report on the surveillance of antimicrobial resistance in bacteria associated with animal husbandry including livestock, poultry and aquaculture has opined that the antibiotic-resistant bacteria emerging in animal husbandry can potentially spread to human populations [130].”
BackgroundInfluentialElevated Risk of Carrying Gentamicin-Resistant Escherichia coli among U.S. Poultry Workers
Price, L. B., Graham, J. P., Lackey, L. G., Roess, A., Vailes, R., & Silbergeld, E. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.10191 · Cited by 108 · cited 1×
“coli compared with community referents [94].”
Streptomycin Resistance of Coliform Bacteria from Turkeys Fed Streptomycin
Starr, M. P., & Reynolds, D. M. (1951) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.41.11_pt_1.1375 · Cited by 99 · cited 1×
“coli isolated from the gut of chickens fed with streptomycin [86].”
BackgroundEmerging Issues in Antimicrobial Resistance of Bacteria from Food-Producing Animals
Michael, G. B., Freitag, C., Wendlandt, S., Eidam, C., Feßler, A. T., Lopes, G. V., Kadlec, K., & Schwarz, Š. (2015) · Future Microbiology · doi:10.2217/fmb.14.93 · Cited by 98 · cited 1×
“Disturbingly, enzyme variations emerged in which both the catalytic activities and substrate specificities were greatly enhanced, and these enzymes were collectively called extended spectrum β-lactamases (ESBLs) [18].”
BackgroundAntibiotic resistance by enzyme inactivation: From mechanisms to solutions
De Pascale, G., & Wright, G. D. (2010) · ChemBioChem · doi:10.1002/cbic.201000067 · Cited by 94 · cited 1×
“One of the earliest known resistance mechanisms involved the enzymatic inactivation of antimicrobial agents [16].”
BackgroundBacterial RNA polymerase: a promising target for the discovery of new antimicrobial agents.
Chopra, I. (2007) · PubMed · Cited by 93
Varga, C., Rajić, A., McFall, M. E., Reid‐Smith, R. J., Deckert, A., Checkley, S., & McEwen, S. A. (2008) · Preventive Veterinary Medicine · doi:10.1016/j.prevetmed.2008.10.002 · Cited by 91
Walther, C., Rossano, A., Thomann, A., & Perreten, V. (2008) · Veterinary Microbiology · doi:10.1016/j.vetmic.2008.03.008 · Cited by 85
Inglis, G. D., McAllister, T. A., Busz, H. W., Yanke, L. J., Morck, D. W., Olson, M. E., & Read, R. R. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.7.3872-3881.2005 · Cited by 81 · cited 1×
“A strong correlation between the use of sub-therapeutic concentrations of tetracycline, alone or in combination with sulfamethazine, and the carriage of resistant strains of Campylobacter species in feedlot cattle has been demonstrated [97].”
BackgroundLambert, T. (2012) · Scientific and Technical Review (World Organisation for Animal Health) · doi:10.20506/rst.31.1.2095 · Cited by 76 · cited 1×
“Extensively studied bacterial targets include cellular machinery for the synthesis of proteins, such as the ribosome [24], as well as the syntheses of bacterial cell walls, such as transpeptidases [25], or of nucleic acids, such as DNA gyrase [26] and RNA polymerase [27].”
BackgroundFunctional principles of solute transport systems: concepts and perspectives
Krämer, R. (1994) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(94)90189-9 · Cited by 71 · cited 1×
“Secondary active transport systems use ion gradients generated by respiration as the driving energy force required for active drug efflux [44,45], and include the resistance-nodulation-cell division (RND) superfamily [46], the small multidrug resistance (SMR) superfamily [47], the multidrug and toxic compound extrusio…”
BackgroundZhang, Q., Zhang, Q., Lin, J., & Pereira, S. G. (2003) · Animal Health Research Reviews · doi:10.1079/ahr200356 · Cited by 70
Human Infections with Staphylococcus aureus CC398
Smith, T. C., & Wardyn, S. E. (2015) · Current Environmental Health Reports · doi:10.1007/s40572-014-0034-8 · Cited by 69 · cited 1×
“A particular sequence type, ST398, of livestock-associated MRSA (LA-MRSA) has also been found in farm facilities and in farm workers [108].”
BackgroundTherapeutic antibiotics in animal feeds and antibiotic resistance
Tollefson, L., Altekruse, S. F., & Potter, M. E. (1997) · Scientific and Technical Review (World Organisation for Animal Health) · doi:10.20506/rst.16.2.1054 · Cited by 69 · cited 1×
“In European Union countries, antibiotic use in farm animals requires prescriptions [135], and along similar lines, the FDA has made a prescription-based administration of its new class of veterinary feed directive (VFD) antibiotics [136].”
BackgroundSmith, K. P., Kumar, S. H., & Varela, M. F. (2009) · Archives of Microbiology · doi:10.1007/s00203-009-0521-8 · Cited by 64 · cited 1×
“Secondary active transport systems use ion gradients generated by respiration as the driving energy force required for active drug efflux [44,45], and include the resistance-nodulation-cell division (RND) superfamily [46], the small multidrug resistance (SMR) superfamily [47], the multidrug and toxic compound extrusio…”
BackgroundSelf-citationBacterial Multidrug Efflux Pumps of the Major Facilitator Superfamily as Targets for Modulation
Kumar, S. H., He, G.-X., Kakarla, P., Shrestha, U., Ranjana, K. C., Ranaweera, I., Willmon, T. M., Barr, S. R., Hernandez, A. J., & Varela, M. F. (2016) · Infectious Disorders - Drug Targets · doi:10.2174/1871526516666160407113848 · Cited by 58 · cited 1×
“Although the crystal structures have been solved for only a few key multidrug efflux pumps [50], these MFS multidrug efflux pumps make good targets for modulation, such as inhibition [55,56], in order to restore the clinical efficacy”
BackgroundSelf-citationvan Cleef, B. A. G. L., van Benthem, B. H. B., Verkade, E. J. M., van Rijen, M. M. L., Kluytmans-van den Bergh, M. F. Q., Graveland, H., Bosch, T., Verstappen, K. M. H. W., Wagenaar, J. A., Bos, M. E. H., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0127190 · Cited by 56 · cited 1×
“Antibiotic-resistant bacteria associated with food animals has resulted in their dissemination via the food chain and into the environment, and in farm workers being the carriers of such bacteria [81,93].”
BackgroundBacterial resistance to antibiotics as a function of outer membrane permeability
Nikaido, H. (1988) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/22.supplement_a.17 · Cited by 49 · cited 1×
“A fourth bacterial resistance mechanism relies on the ability of the bacterium to reduce the entry of the antimicrobial agent into the cytoplasm [34].”
BackgroundWegener, H. C. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.11.3049 · Cited by 48 · cited 1×
“According to one estimate, 24,000 kg of active avoparcin was used in Denmark in animals compared to the 24 kg used in humans [75].”
MethodManning, J. G., Hargis, B. M., Hinton, A., Corrier, D. E., DeLoach, J. R., & Creger, C. R. (1994) · Avian Diseases · doi:10.2307/1591946 · Cited by 41 · cited 1×
“Medicated feeds, apart from their effect on growth, have helped the animal industry to control several serious infectious diseases associated with farm animals and birds [77,78].”
BackgroundStructural comparison of bacterial multidrug efflux pumps of the major facilitator superfamily.
Ranaweera, I., Shrestha, U., Ranjana, K. C., Kakarla, P., Willmon, T. M., Hernandez, A. J., Mukherjee, M. M., Barr, S. R., & Varela, M. F. (2015) · PubMed · Cited by 36
Self-citationPatterns and Determinants of Inappropriate Antibiotic Use in Injection Drug Users
Starrels, J. L., Barg, F. K., & Metlay, J. P. (2008) · Journal of General Internal Medicine · doi:10.1007/s11606-008-0859-7 · Cited by 30
Rajić, A., McFall, M. E., Deckert, A., Reid‐Smith, R. J., Manninen, K., Poppe, C., Dewey, C. E., & McEwen, S. A. (2004) · Veterinary Microbiology · doi:10.1016/j.vetmic.2004.09.013 · Cited by 27
[History of antibiotics and sulphonamides discoveries].
Jeśman, C., Młudzik, A., & Cybulska, M. (2011) · PubMed · Cited by 25
Varga, C., Rajić, A., McFall, M. E., Reid‐Smith, R. J., & McEwen, S. A. (2008) · Foodborne Pathogens and Disease · doi:10.1089/fpd.2008.0118 · Cited by 25
Kyriakis, S. C., Tsinas, A., Lekkas, S., Sarris, K., & Bourtzi-Hatzopoulou, E. (1996) · Veterinary Record · doi:10.1136/vr.138.20.489 · Cited by 17 · cited 1×
“Medicated feeds, apart from their effect on growth, have helped the animal industry to control several serious infectious diseases associated with farm animals and birds [77,78].”
BackgroundEffect of Antibacterial Agents on Growth of Baby Pigs Fed a "Synthetic" Diet
Wahlstrom, R. C., Terrill, S. W., & Johnson, B. C. (1950) · Experimental Biology and Medicine · doi:10.3181/00379727-75-18314 · Cited by 15 · cited 1×
“The growth-promoting effect of streptomycin also prompted its use in farm animal feed [62].”
BackgroundAntibiotics in Food Preservation
Farber, L. (1959) · Annual Review of Microbiology · doi:10.1146/annurev.mi.13.100159.001013 · Cited by 4
Research works printed but not linked: 6
- Kumar, S., Floyd, J.T., He, G., and Varela, M.F. (2013). Bacterial Antimicrobial Efflux Pumps of the MFS and Mate Transporter Families: A Review, Research Signpost Inc.
- Prescott, J., and Baggot, J. (1993). Antimicrobial Therapy in Veterinary Medicine, Iowa State University Press. [2nd ed.].
- (2015). Antimicrobials in Agriculture and the Environment: Reducing Unnecessary Use and Wastage. The Review on Antimicrobial Resistance, Antimicrobial Resistance Review (AMR).
- NIAA (2011, January 26–27). Antibiotic Use in Food Animals: A Dialogue for a Common Purpose. Proceedings of the Symposium by National Institute for Animal Agriculture and Conducted, Chicago, IL, USA.
- Vaughn, M., and Copeland, D. (2004, January 6–9). Is there human health harm following fluoroquinolone use in poultry?. Proceedings of the Fifty-Third Western Poultry Disease Conference, Sacramento, CA, USA.
- FAO (2007, January 26–30). Joint FAO/WHO/OIE expert meeting on critically important antimicrobials. Proceedings of the FAO/WHO/OIE Expert Meeting FAO Headquarters, Rome, Italy.
Cited by
Muteeb, G., Rehman, M. T., Shahwan, M., & Aatif, M. (2023) · Pharmaceuticals · doi:10.3390/ph16111615 · Cited by 1,215
Antibiotic use in food animals worldwide, with a focus on Africa: Pluses and minuses
Van, T. T. H., Yidana, Z., Smooker, P. M., & Coloe, P. J. (2020) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2019.07.031 · Cited by 451
An Overview of the Recent Advances in Antimicrobial Resistance
Oliveira, M., Antunes, W., Mota, S., Madureira-Carvalho, Á., Dinis-Oliveira, R. J., & Dias da Silva, D. (2024) · Microorganisms · doi:10.3390/microorganisms12091920 · Cited by 285
“Effective clinician–patient communication is essential to provide clear explanations, use specific diagnoses, and offer alternative treatments to reduce unnecessary antibiotic prescription while maintaining patient satisfaction [349].”
Antimicrobial uses for livestock production in developing countries
Hosain, M. Z., Kabir, S. M. L., & Kamal, M. M. (2021) · Veterinary World · doi:10.14202/vetworld.2021.210-221 · Cited by 201
“Penicillin and tetracyclines are the most commonly prescribed antibiotics used for food animals [47], whereas for human therapeutic purpose antimicrobial drug categories as the macrolides, polymyxins, aminoglycosides, and third-generation cephalosporins (Table-2), which are also being used in food animals [8,19,48,49].”
BackgroundSelection and dissemination of antimicrobial resistance in Agri-food production
Cheng, G., Ning, J., Ahmed, S., Huang, J., Ullah, R., An, B., Hao, H., Dai, M., Huang, L., Wang, X., et al. (2019) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-019-0623-2 · Cited by 195
“In United States, nearly 80% of antibiotics produced are used in animal husbandry [2].”
Metadata
- Authors
- Lekshmi, M., Ammini, P., Kumar, S., & Varela, M. F.
- Affiliations
- Central Institute of Fisheries Education (IN)
- CSIR-National Institute of Oceanography (NIO), Regional Centre, Dr. Salim Ali Road, Kochi 682018, India
- Eastern New Mexico University (US)
- Corresponding author
- Varela, Manuel F.
- Venue
- Microorganisms
- Publisher
- MDPI AG
- Published
- 2017-03-14
- Volume
- 5
- Issue
- 1
- Pages
- 11
- ISSN
- 2076-2607 (ISSN-L)
- PMC
- PMC5374388
- OpenAlex
- W2595170873
- Cited by
- 194
- References
- 122
- Citations by year
- 2026: 12 · 2025: 16 · 2024: 18 · 2023: 37 · 2022: 26 · 2021: 25 · 2020: 30 · 2019: 13 · 2018: 15 · 2017: 2
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Microorganisms (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- European Food Safety Authority
- National Institutes of Health
- Centers for Disease Control and Prevention
- National Institute of General Medical Sciences (P20GM103451)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Life Sciences › Agricultural and Biological Sciences › Food Science › Salmonella and Campylobacter epidemiology
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- antimicrobial resistance, food production, zoonotic pathogens, antibiotic growth promoters, foodborne pathogens, Campylobacter, Salmonella, Escherichia coli, Staphylococcus aureus, antibiotic use in livestock, human health risk, critical antimicrobials, trophic transfer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
![Figure 1 Global antimicrobial use in food animals (a) Major users of antimicrobials in livestock in 2010; (b) Major users of antimicrobials in livestock in 2030 (projected) [65].](https://figures.cochat.ai/paper-figures/0cf0592b99b94604b99caca67c3146f9/the-food-production-environment-and-the-development-of-antimicrobial-resistance-figure-1.jpg)